Literature DB >> 23934183

Asiatic acid inhibits adipogenic differentiation of bone marrow stromal cells.

Zheng-Wei Li1, Cheng-dong Piao, Hong-hui Sun, Xian-Sheng Ren, Yun-Shen Bai.   

Abstract

Bone marrow mesenchymal stromal cells (BMSCs) are the common precursors for both osteoblasts and adipocytes. With aging, BMSC osteoblast differentiation decreases whereas BMSC differentiation into adipocytes increases, resulting in increased adipogenesis and bone loss. In the present study, we investigated the effect of asiatic acid (AA) on adipocytic differentiation of BMSCs. AA inhibited the adipogenic induction of lipid accumulation, activity of glycerol-3-phosphate dehydrogenase, and expression of marker genes in adipogenesis: peroxisome proliferation-activated receptor (PPAR)γ, adipocyte fatty acid-binding protein (ap) 2, and adipsin. Further, we found that AA did not alter clonal expansion rate and expression of C/EBPβ, upstream key regulator of PPARγ, and binding activity of C/EBPβ to PPARγ promoter was not affected by AA as well. These findings suggest that AA may modulate differentiation of BMSCs to cause a lineage shift away from the adipocytes, and inhibition of PPARγ by AA is through C/EBPβ-independent mechanisms. Thus, AA could be a potential candidate for a novel drug against osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23934183     DOI: 10.1007/s12013-013-9725-2

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  2 in total

1.  Asiatic acid improves high-fat-diet-induced osteoporosis in mice via regulating SIRT1/FOXO1 signaling and inhibiting oxidative stress.

Authors:  Xiaosi Chen; Dengpeng Han; Tianfeng Liu; Chengshuo Huang; Zibing Hu; Xiaoyan Tan; Shaoke Wu
Journal:  Histol Histopathol       Date:  2022-03-01       Impact factor: 2.130

2.  BMP14 induces tenogenic differentiation of bone marrow mesenchymal stem cells in vitro.

Authors:  Dan Wang; Xinhao Jiang; Aiqing Lu; Min Tu; Wei Huang; Ping Huang
Journal:  Exp Ther Med       Date:  2018-06-12       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.